The National Science Foundation (NSF) Innovation Corps (I-CorpsTM) Northeast Hub is part of a nationwide NSF-funded network of universities formed to accelerate the economic impact of federally funded research – delivering benefits in health care, the environment, technology and other areas – while building skills and opportunities among researchers from all backgrounds, including those historically underrepresented in entrepreneurship.
Verismo Therapeutics is a pioneer in dual-chain KIR-CAR technology, with its lead asset SynKIR™️-110 undergoing first-in-human clinical trial. Verismo is the only company developing the KIR-CAR platform, a modified NK-like receptor designed to improve persistence and efficacy against aggressive solid tumors. The KIR-CAR platform technology was developed specifically for advanced solid tumors, an area of high unmet medical need. Verismo Therapeutics was awarded The Best Place To Work in 2023 award by the Philadelphia Business Journal.
CIC’s mission is to fix the world through innovation by creating the best possible environment and programming to enable startups, scale-ups, corporations, and public entities to tackle the biggest local and global challenges while fostering growth and connection.
CIC today manages more than 1.2M square feet of workspace, laboratories, and event space across North America, Europe, and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation.
Our vision is to become a trusted leader in flow cytometry contract research organization (CRO) services. We are committed to aiding scientists and healthcare professionals in their essential work, striving to drive progress in disease understanding and treatment development with our dedicated flow cytometry expertise.
Our mission is to provide flow cytometry and cell sorting expertise and services to researchers in pharmaceutical, biotech, and clinical laboratories.
Our goal is to make flow cytometry services accessible and affordable by providing cost-effective research solutions and expert technical support.
Life Science Cares activates the financial and human capital of the life sciences industry and partners with nonprofits to disrupt the cycle of poverty and inequality in our communities. We envision all of our neighbors having access to basic needs, access to education, and access to opportunity.
With over 375,000 Philadelphia residents living below the poverty line, Life Science Cares Philadelphia is committed to uniting the life science community and providing human and financial resources to organizations that support survival, education and sustainability.
The Department of Commerce helps businesses—large and small—thrive in Philadelphia. Philadelphia is the perfect home for your business, offering:
We work to: